ATLANTA (CIDRAP News) The vital role of preparedness, from diagnostic testing to stockpiling of antiviral medications, was one of the most important lessons from assessments of the world's response to the H1N1 influenza pandemic, the World Health Organization's (WHO's) top flu expert told an international infectious diseases conference yesterday.
(CIDRAP News) – Indonesia's recent announcement that it would immediately begin sharing H5N1 avian influenza genetic sequences with a new public database is being hailed by experts as a promising development, though there is a concern that having actual virus isolates would be better.
Indonesia's decision, announced by Health Minister Siti Fadilah Supari, was detailed in a May 15 report from the Associated Press (AP).
(CIDRAP News) An official from the US Centers for Disease Control and Prevention (CDC), which is a collaborating laboratory for the World Health Organization (WHO), today said Indonesia's health ministry is sending 15 H5N1 influenza samples for virus characterization, the first the country has shared since last year.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) Indonesian officials said today they have sent a sample from a recent victim of H5N1 influenza to the World Health Organization (WHO), apparently ending the country's prolonged withholding of H5N1 samples.
TORONTO (CIDRAP News) The continuing debate over developing countries' ability to afford pandemic-influenza vaccines has produced a disturbing complication: the possibility that Indonesia and other countries affected by H5N1 avian flu will assert legal ownership of the viral isolates on which the vaccines would be based.
(CIDRAP News) Some of the H5N1 avian flu virus samples from human cases that China has promised to send to a World Health Organization (WHO) laboratory have arrived in the United States, apparently ending an almost year-long lapse in sample sharing.